831 related articles for article (PubMed ID: 19162490)
61. Catalytic properties of [Pd(COOMe)(n)X(2-n)(PPh(3))(2)] (n = 0, 1, 2; X = Cl, NO(2), ONO(2), OAc and OTs) in the oxidative carbonylation of MeOH.
Amadio E; Cavinato G; Dolmella A; Toniolo L
Inorg Chem; 2010 Apr; 49(8):3721-9. PubMed ID: 20334352
[TBL] [Abstract][Full Text] [Related]
62. Synthesis, characterization and cytotoxicity of mixed-ligand complexes of palladium(II) with 2, 2'-biquinoline/1, 4-diaminobutane and 4-toluenesulfonyl-L-amino acid dianion.
Zhang J; Li L; Ma L; Zhang F; Zhang Z; Wang S
Eur J Med Chem; 2011 Nov; 46(11):5711-6. PubMed ID: 21907465
[TBL] [Abstract][Full Text] [Related]
63. New pH-dependent complexes, from mononuclear Pd(II) monomer to heteronuclear [Pd(II),K(I)]Polymer: DNA cleavage and cytotoxicity in vitro.
Gao EJ; Zhu MC; Huang Y; Liu L; Liu HY; Liu FC; Ma S; Shi CY
Eur J Med Chem; 2010 Mar; 45(3):1034-41. PubMed ID: 20015578
[TBL] [Abstract][Full Text] [Related]
64. New palladium(II) complexes bearing pyrazole-based Schiff base ligands: synthesis, characterization and cytotoxicity.
Abu-Surrah AS; Abu Safieh KA; Ahmad IM; Abdalla MY; Ayoub MT; Qaroush AK; Abu-Mahtheieh AM
Eur J Med Chem; 2010 Feb; 45(2):471-5. PubMed ID: 19913953
[TBL] [Abstract][Full Text] [Related]
65. Synthesis, structural, physico-chemical and biological properties of new palladium(II) complexes with 2,6-dimethyl-4-nitropyridine.
Kuduk-Jaworska J; Puszko A; Kubiak M; Pełczyńska M
J Inorg Biochem; 2004 Aug; 98(8):1447-56. PubMed ID: 15271523
[TBL] [Abstract][Full Text] [Related]
66. Impact of the carbon chain length of novel palladium(II) complexes on interaction with DNA and cytotoxic activity.
Gao E; Zhu M; Liu L; Huang Y; Wang L; Shi C; Zhang W; Sun Y
Inorg Chem; 2010 Apr; 49(7):3261-70. PubMed ID: 20199051
[TBL] [Abstract][Full Text] [Related]
67. Study of benzo[a]phenazine 7,12-dioxide as selective hypoxic cytotoxin-scaffold. Identification of aerobic-antitumoral activity through DNA fragmentation.
Lavaggi ML; Cabrera M; Aravena Mde L; Olea-Azar C; López de Ceráin A; Monge A; Pachón G; Cascante M; Bruno AM; Pietrasanta LI; González M; Cerecetto H
Bioorg Med Chem; 2010 Jun; 18(12):4433-40. PubMed ID: 20471844
[TBL] [Abstract][Full Text] [Related]
68. Spectroscopic and cytotoxic studies of the novel designed palladium(II) complexes: beta-lactoglobulin and K562 as the targets.
Divsalar A; Saboury AA; Yousefi R; Moosavi-Movahedi AA; Mansoori-Torshizi H
Int J Biol Macromol; 2007 Mar; 40(4):381-6. PubMed ID: 17097727
[TBL] [Abstract][Full Text] [Related]
69. Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency.
Buravchenko GI; Scherbakov AM; Dezhenkova LG; Bykov EE; Solovieva SE; Korlukov AA; Sorokin DV; Monzote Fidalgo L; Shchekotikhin AE
Bioorg Chem; 2020 Nov; 104():104324. PubMed ID: 33142432
[TBL] [Abstract][Full Text] [Related]
70. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
Peri D; Meker S; Shavit M; Tshuva EY
Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
[TBL] [Abstract][Full Text] [Related]
71. First bivalent palladium and platinum cyanoximates: synthesis, characterization, and biological activity.
Eddings D; Barnes C; Gerasimchuk N; Durham P; Domasevich K
Inorg Chem; 2004 Jun; 43(13):3894-909. PubMed ID: 15206870
[TBL] [Abstract][Full Text] [Related]
72. Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide.
Lee HH; Wilson WR; Ferry DM; van Zijl P; Pullen SM; Denny WA
J Med Chem; 1996 Jun; 39(13):2508-17. PubMed ID: 8691448
[TBL] [Abstract][Full Text] [Related]
73. Synthesis, crystal structure, DNA-binding and cytotoxicity in vitro of novel cis-Pt(II) and trans-Pd(II) pyridine carboxamide complexes.
Shi CY; Gao EJ; Ma S; Wang ML; Liu QT
Bioorg Med Chem Lett; 2010 Dec; 20(24):7250-4. PubMed ID: 21071219
[TBL] [Abstract][Full Text] [Related]
74. Chiral cyclopalladated complexes derived from N,N-dimethyl-1-phenethylamine with bridging bis(diphenylphosphine)ferrocene ligand as inhibitors of the cathepsin B activity and as antitumoral agents.
Bincoletto C; Tersariol IL; Oliveira CR; Dreher S; Fausto DM; Soufen MA; Nascimento FD; Caires AC
Bioorg Med Chem; 2005 Apr; 13(8):3047-55. PubMed ID: 15781414
[TBL] [Abstract][Full Text] [Related]
75. Structure-activity relationships of 1,2,4-benzotriazine 1,4-dioxides as hypoxia-selective analogues of tirapazamine.
Hay MP; Gamage SA; Kovacs MS; Pruijn FB; Anderson RF; Patterson AV; Wilson WR; Brown JM; Denny WA
J Med Chem; 2003 Jan; 46(1):169-82. PubMed ID: 12502371
[TBL] [Abstract][Full Text] [Related]
76. Synthesis of some new 4-styryltetrazolo[1,5-a]quinoxaline and 1-substituted-4-styryl[1,2,4]triazolo[4,3-a]quinoxaline derivatives as potent anticonvulsants.
Wagle S; Adhikari AV; Kumari NS
Eur J Med Chem; 2009 Mar; 44(3):1135-43. PubMed ID: 18672315
[TBL] [Abstract][Full Text] [Related]
77. Organometallic anticancer agents: cellular uptake and cytotoxicity studies on thiol derivatives of the antitumor agent molybdocene dichloride.
Waern JB; Dillon CT; Harding MM
J Med Chem; 2005 Mar; 48(6):2093-9. PubMed ID: 15771451
[TBL] [Abstract][Full Text] [Related]
78. Tricarbonyl M(I) (M = Re, (99m)Tc) complexes bearing acridine fluorophores: synthesis, characterization, DNA interaction studies and nuclear targeting.
Esteves T; Xavier C; Gama S; Mendes F; Raposinho PD; Marques F; Paulo A; Pessoa JC; Rino J; Viola G; Santos I
Org Biomol Chem; 2010 Sep; 8(18):4104-16. PubMed ID: 20648265
[TBL] [Abstract][Full Text] [Related]
79. Synthesis, cytotoxic effect, and structure-activity relationship of Pd(II) complexes with coumarin derivatives.
Budzisz E; Małecka M; Lorenz IP; Mayer P; Kwiecień RA; Paneth P; Krajewska U; Rózalski M
Inorg Chem; 2006 Nov; 45(24):9688-95. PubMed ID: 17112264
[TBL] [Abstract][Full Text] [Related]
80. Synthesis, characterization, in vitro antitumoral investigations and interaction with plasmid pBR322 DNA of R2eddp-platinum(IV) complexes (R = Et, n-Pr).
Kaluderović GN; Kommera H; Schwieger S; Paethanom A; Kunze M; Schmidt H; Paschke R; Steinborn D
Dalton Trans; 2009 Dec; (48):10720-6. PubMed ID: 20023900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
